NCT00532610View on ClinicalTrials.gov

A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Type 2 Diabetes MellitusDiabetes Mellitus, Type 2

Interventions

DRUG

GSK189075

Trial Locations (1)

53704

GSK Investigational Site, Madison

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY